← Evidence map

TrialPloS one2026

Patient characteristics associated with the need for high doses of tenapanor hydrochloride in dialysis patients with hyperphosphatemia: A pooled analysis of three clinical trials.

Nobuo Nagano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

3 trials

Full record →Abstract, authors, funding and every citing paper · PMID 42664364